Gastric Cancer Clinical Trials
Gastric Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for gastric Cancer. Corterve aggregates actively recruiting Gastric Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Gastric Cancer studies
- A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsNCT06427941PHASE1BeOne MedicinesGoodyear, Arizona
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2NCT06219941PHASE2AstraZenecaOrange, California
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerNCT07392892PHASE2, PHASE3PfizerAurora, Colorado
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)NCT04198766PHASE1, PHASE2Inhibrx Biosciences, IncDuarte, California
- Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialNCT06203600PHASE2, PHASE3National Cancer Institute (NCI)Little Rock, Arkansas
- Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic AnalysisNCT04557969National Cancer Institute (NCI)Bethesda, Maryland
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsNCT03526835PHASE1, PHASE2Merus B.V.La Jolla, California
- A Study of MRG007 (ARR-217) in Patients With Advanced Solid TumorsNCT07066657PHASE1ArriVent BioPharma, Inc.Los Angeles, California
- IDOV-Immune for Advanced Solid TumorsNCT06910657PHASE1ViroMissile, Inc.St Louis, Missouri
- Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsNCT06974110PHASE1MOMA TherapeuticsPhoenix, Arizona
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsNCT05208762PHASE1Seagen, a wholly owned subsidiary of PfizerBirmingham, Alabama
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerNCT04329494PHASE1City of Hope Medical CenterDuarte, California
Gastric Cancer trials by state
Gastric Cancer trials by metro
Frequently asked questions
- How do I find recruiting Gastric Cancer clinical trials?
- Corterve aggregates actively recruiting Gastric Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Gastric Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Gastric Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.